Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 3:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 6,925 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Control, small Clear all

Conditions: Asthma
Interventions: Jet Nebulizer, Vibrating Mesh Nebulizer; Device
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 2 Years to 18 Years
Enrollment: 220 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Type 2 Diabetes
Interventions: Breakfast; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 80 Years
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Halitosis
Interventions: Biofresh® 4plus, Placebo; Dietary Supplement
Lead sponsor: Novozymes A/S; Industry
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Diabetes type2, Obesity
Interventions: RESET Liner, Sham; Device · Other
Lead sponsor: Morphic Medical Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 264 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2029
U.S. locations: 27
States / cities: Gilbert, Arizona • Tucson, Arizona • Washington D.C., District of Columbia + 22 more

Conditions: Ischemic Heart Disease, Hopelessness, Physical Activity, Motivation, Social Support, Covid19
Interventions: Motivational social support from nurse, Motivational social support from nurse with additional support from significant other, Attention control; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years and older
Enrollment: 224 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Diabetes Mellitus, Type 2
Interventions: Pharmacy Managed Diabetes Clinic (PMDC), Standard of Care (SOC); Behavioral · Other
Lead sponsor: Corewell Health East; Other
Eligibility: 18 Years to 75 Years
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 4
States / cities: Berkley, Michigan • Royal Oak, Michigan • Southfield, Michigan + 1 more

Conditions: Healthy Subjects
Interventions: Placebo, MEDI7814, 1 MG/KG, MEDI7814, 3 MG/KG, MEDI7814, 10 MG/KG, MEDI7814, 20 MG/KG; Other · Biological
Lead sponsor: MedImmune LLC; Industry
Eligibility: 18 Years to 49 Years
Enrollment: 125 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Maternal Health
Interventions: Low Touch - Text Messaging Implementation Strategy, High Touch - Community Health Worker (CHW) Implementation Strategy; Behavioral
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 89 Years · Female only
Enrollment: 1,050 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: New York, New York

Conditions: Irritable Bowel Syndrome (IBS-C)
Interventions: Transcutaneous Auricular Vagus Nerve Stimulation (ta-VNS), Sham Transcutaneous Auricular Vagus Nerve Stimulation; Device
Lead sponsor: West Virginia University; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Morgantown, West Virginia

Conditions: Anemia
Interventions: Ferric Carboxymaltose, Standard Medical Care (SMC); Drug
Lead sponsor: American Regent, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 735 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Norristown, Pennsylvania

Conditions: Depression Mild, Depression Moderate
Interventions: Yoga practice, Education; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pelvic Floor Myofascial Pain, Pelvic Pain, Myofascial Pain
Interventions: vaginal cryotherapy; Device
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 165 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Infant, Extremely Premature, Length of Stay, Feeding
Interventions: NTrainer® Intervention, Control Intervention; Device
Lead sponsor: KC BioMediX, Inc; Industry
Eligibility: 26 Weeks to 31 Weeks
Enrollment: 210 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2016
U.S. locations: 5
States / cities: San Jose, California • The Bronx, New York • Fort Worth, Texas + 1 more

Conditions: Periodontal Diseases
Interventions: Connective Tissue Graft Technique, Pinhole Surgical Technique; Procedure
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 19 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Spinal Muscular Atrophy
Interventions: Nusinersen, Sham Procedure; Drug · Procedure
Lead sponsor: Biogen; Industry
Eligibility: Not listed
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Los Angeles, California • Hartford, Connecticut • Baltimore, Maryland + 3 more

Conditions: Opioid Dependence
Interventions: Vivitrol, Employment-based opiate abstinence reinforcement, Usual Care Control; Drug · Behavioral · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Pain, Chronic Pain, Breakthrough Pain
Interventions: Fentanyl Buccal Tablets; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 218 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 33
States / cities: Birmingham, Alabama • Phoenix, Arizona • Anaheim, California + 29 more

Conditions: Anxiety Disorder, Breast Cancer, Depression, Fatigue, Hot Flashes, Pain, Sleep Disorders
Interventions: acupuncture therapy, sham intervention; Procedure
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older · Female only
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Primary Malignant Brain Tumor, Glioblastoma (GBM), Astrocytoma, Oligodendroglioma, Caregiver
Interventions: Fearless in Neuro-Oncology; Behavioral
Lead sponsor: Virginia Commonwealth University; Other
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Richmond, Virginia

Conditions: Nicotine Use Disorder
Interventions: Retrieval Extinction Training (RET), Control Retrieval Extinction Training (RET); Behavioral
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 25 Years to 65 Years
Enrollment: 191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Kidney Transplant; Complications
Interventions: Discharge Mentoring; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 70 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Non-small Cell Lung Cancer
Interventions: Intismeran autogene, Pembrolizumab, Placebo; Biological · Other
Lead sponsor: Merck Sharp & Dohme LLC; Industry
Eligibility: 18 Years and older
Enrollment: 868 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2035
U.S. locations: 68
States / cities: Anchorage, Alaska • Tucson, Arizona • Yuma, Arizona + 55 more

Conditions: Advanced Care Planning (ACP)
Interventions: Transtheoretical Model (TTM) of health behavior change, Usual Care; Behavioral · Other
Lead sponsor: Yale University; Other
Eligibility: 55 Years and older
Enrollment: 909 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Heart Failure
Interventions: Gentle Stretching and Education; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 19 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Search by objective public record fields.

Comparison of Vibrating Mesh Nebulizer Versus Jet Nebulizer in the Pediatric Asthma Patient

The Breakfast Study

Effect of an Investigational Lozenge (Biofresh® 4plus) Versus Placebo Control on Oral Malodor (Intra-Oral Halitosis)

The RESET System Pivotal Clinical Trial (Protocol Revision K)

Reducing Hopelessness Through Improved Physical Activity in Adults With Heart Disease: With COVID-19 Considerations

Impact of Pharmacy Clinic on Diabetes Management

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

RESTORE - Phase II

Trans Auricular Vagal Nerve Stimulation in Patients With IBS-C

Safety and Tolerability of a Single Dose of FCM vs. Standard of Care in Treating Iron Deficiency Anemia

Treating Major Depression With Yoga Mono-therapy

Randomized Controlled Trial of Vaginal Cryotherapy for Pelvic Floor Myofascial Pain

Trial of Patterned Oral Somatosensory Entrainment for Shortening Time to Oral Feeding

Pinhole Surgical Technique Compared to Connective Tissue Graft in Treatment of Gingival Recession

A Study to Assess the Safety and Tolerability of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy (SMA).

The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence

Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain

Acupuncture in Reducing Muscle and Bone Symptoms in Women Receiving Letrozole, Exemestane, or Anastrozole for Stage 0, Stage I, Stage II, or Stage III Breast Cancer

FearLess in NeuroOncology

Behavioral Memory Modulation in Nicotine Addiction

Design of a Standardized Patient: Mentoring Program for Kidney Transplant Patients

A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

STAMP: Sharing and Talking About My Preferences

Getting Into Light Exercise for Patients With Heart Failure